Entera Bio (ENTX) Short Interest Ratio & Short Volume → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free ENTX Stock Alerts $2.31 -0.07 (-2.94%) (As of 04:00 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Entera Bio Short Interest DataCurrent Short Interest35,200 sharesPrevious Short Interest89,900 sharesChange Vs. Previous Month-60.85%Dollar Volume Sold Short$68,992.00Short Interest Ratio0.1 Days to CoverLast Record DateApril 30, 2024Outstanding Shares23,740,000 sharesPercentage of Shares Shorted∞Today's Trading Volume162,914 sharesAverage Trading Volume202,603 sharesToday's Volume Vs. Average80% Short Selling Entera Bio ? Sign up to receive the latest short interest report for Entera Bio and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartENTX Short Interest Over TimeENTX Days to Cover Over TimeENTX Percentage of Float Shorted Over Time Ad Weiss RatingsWhat is Nvidia’s New $1 Trillion Superproject?Nvidia recently added $277 billion in market cap … IN ONE DAY.Find out details on these three critical Nvidia partners immediately. Entera Bio Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202435,200 shares $68,992.00 -60.9%N/A0.1 $1.96 4/15/202489,900 shares $226,548.00 +1.9%N/A0.4 $2.52 3/31/202488,200 shares $147,294.00 +988.9%N/A0.5 $1.67 3/15/20248,100 shares $11,097.00 +523.1%N/A0.1 $1.37 2/29/20241,300 shares $1,787.50 -95.0%N/A0 $1.38 2/15/202426,100 shares $27,405.00 +715.6%N/A0.3 $1.05 Get the Latest News and Ratings for ENTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Entera Bio and its competitors with MarketBeat's FREE daily newsletter. 1/31/20243,200 shares $2,655.36 -80.5%N/A0 $0.83 1/15/202416,400 shares $17,876.00 -73.9%0.1%0.2 $1.09 12/31/202362,800 shares $37,680.00 +5.7%0.3%1.2 $0.60 12/15/202359,400 shares $39,055.50 -13.0%0.3%1.7 $0.66 11/30/202368,300 shares $47,919.28 -3.1%0.3%2.1 $0.70 11/15/202370,500 shares $50,492.10 +29.6%0.3%2.1 $0.72 10/31/202354,400 shares $37,302.08 +8.8%0.3%1.3 $0.69 10/15/202350,000 shares $36,500.00 -16.0%0.2%1.2 $0.73 9/30/202359,500 shares $43,137.50 +18.3%0.3%1.5 $0.73 9/15/202350,300 shares $34,455.50 +89.1%0.2%1.3 $0.69 8/31/202326,600 shares $17,822.00 +24.9%0.1%0.8 $0.67 8/15/202321,300 shares $12,782.13 -42.7%0.1%0.6 $0.60 7/31/202337,200 shares $29,388.00 +268.3%0.2%1.3 $0.79 7/15/202310,100 shares $8,560.76 -55.5%0.1%0.3 $0.85 6/30/202322,700 shares $19,145.18 +291.4%0.1%0.7 $0.84 6/15/20235,800 shares $4,871.43 -82.3%0.0%0.1 $0.84 5/31/202332,800 shares $26,010.40 -12.8%0.2%0.5 $0.79 5/15/202337,600 shares $38,043.68 -23.7%0.2%0.2 $1.01 4/30/202349,300 shares $37,961.00 -54.5%0.2%0.2 $0.77 4/15/2023108,400 shares $92,627.80 -52.5%0.5%0.5 $0.85 3/31/2023228,200 shares $264,712.00 +22.8%1.0%1 $1.16 3/15/2023185,900 shares $187,759.00 +114.4%0.8%0.8 $1.01 2/28/202386,700 shares $77,683.20 +181.5%0.4%0.4 $0.90 2/15/202330,800 shares $29,059.80 -3.5%0.1%0.5 $0.94 1/31/202331,900 shares $29,284.23 -0.6%0.1%0.3 $0.92 1/15/202332,100 shares $26,643.00 -47.5%N/A0.3 $0.83 12/30/202261,100 shares $44,603.00 +8.5%N/A0.5 $0.73 12/15/202256,300 shares $35,294.47 -8.5%N/A0.5 $0.63 11/30/202261,500 shares $41,746.20 -43.4%N/A0.5 $0.68 11/15/2022108,700 shares $58,458.86 -26.6%N/A0.9 $0.54 10/31/2022148,100 shares $115,895.80 +119.7%N/A1.9 $0.78 10/15/202267,400 shares $56,616.00 +160.2%N/A1 $0.84 9/30/202225,900 shares $26,936.00 -54.8%N/A0.4 $1.04 9/15/202257,300 shares $76,209.00 +38.7%N/A1.7 $1.33Write this ticker symbol down… (Ad)A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made millionaire Tim Bohen is giving you an inside look at the megatrend that’s going to change everything.Discover the #1 company leading this revolution 8/31/202241,300 shares $55,755.00 -5.9%N/A1.1 $1.35 8/15/202243,900 shares $77,703.00 -48.5%N/A1.4 $1.77 7/31/202285,300 shares $165,482.00 +9.1%N/A2.5 $1.94 7/15/202278,200 shares $109,480.00 -11.4%N/A2.4 $1.40 6/30/202288,300 shares $117,439.00 -30.3%N/A2.6 $1.33 6/15/2022126,700 shares $219,191.00 -14.7%N/A3.4 $1.73 5/31/2022148,600 shares $319,490.00 +4.2%N/A4.2 $2.15 5/15/2022142,600 shares $306,590.00 -1.7%N/A3.9 $2.15 4/30/2022145,000 shares $355,250.00 +10.1%N/A3.6 $2.45 4/15/2022131,700 shares $345,054.00 -24.7%N/A2.5 $2.62 3/31/2022174,800 shares $501,676.00 -13.1%N/A2.9 $2.87 3/15/2022201,200 shares $440,628.00 -2.5%N/A1.9 $2.19 2/28/2022206,400 shares $439,632.00 +12.7%N/A1.9 $2.13 2/15/2022183,200 shares $395,712.00 -31.6%N/A1.6 $2.16 1/31/2022267,800 shares $613,262.00 -11.0%N/A2.2 $2.29 1/15/2022300,800 shares $851,264.00 +7.4%N/A0 $2.83 12/31/2021280,000 shares $789,600.00 +9.3%N/A2.4 $2.82 12/15/2021256,300 shares $797,093.00 +5.4%N/A2.9 $3.11 11/30/2021243,100 shares $811,954.00 -16.8%N/A2.6 $3.34 11/15/2021292,200 shares $1.10 million -8.3%N/A2.8 $3.78 10/29/2021318,500 shares $1.36 million -3.7%N/A2.6 $4.26 10/15/2021330,800 shares $1.50 million -11.4%N/A2.1 $4.52 9/30/2021373,200 shares $1.76 million +21.3%N/A1.8 $4.71 9/15/2021307,600 shares $1.41 million -25.4%N/A0.7 $4.59 8/31/2021412,300 shares $2.01 million +119.5%N/A0.1 $4.88 8/13/2021187,800 shares $1.01 million +57.4%1.0%0.1 $5.40 7/30/2021119,300 shares $613,202.00 -33.3%0.6%0 $5.14 7/15/2021178,800 shares $935,124.00 -74.4%1.1%0.1 $5.23 6/30/2021697,100 shares $4.17 million +903.0%4.2%0.2 $5.98 6/15/202169,500 shares $259,235.00 -9.4%0.4%0 $3.73 5/28/202176,700 shares $247,741.00 -15.1%0.5%0 $3.23 5/14/202190,300 shares $263,676.00 -57.1%N/A0 $2.92 4/30/2021210,400 shares $715,360.00 +115.6%N/A0 $3.40 4/15/202197,600 shares $321,104.00 +21.1%N/A0 $3.29 3/31/202180,600 shares $265,980.00 -94.8%N/A0 $3.30 3/15/20211,540,000 shares $10.63 million +1,036.5%N/A0.2 $6.90 2/26/2021135,500 shares $239,835.00 -13.4%N/A0.2 $1.77 2/12/2021156,500 shares $284,830.00 +17.6%N/A0.2 $1.82 1/29/2021133,100 shares $185,009.00 -8.8%N/A0.2 $1.39 1/15/2021145,900 shares $180,916.00 +256.7%N/A0.3 $1.24 12/31/202040,900 shares $44,990.00 -17.4%0.4%0.1 $1.10 12/15/202049,500 shares $52,965.00 +56.7%0.5%0.1 $1.07 11/30/202031,600 shares $33,496.00 -41.2%0.3%0.3 $1.06 11/15/202053,700 shares $56,116.50 +42.1%0.5%0.6 $1.05 10/30/202037,800 shares $41,580.00 +7.4%0.4%0.3 $1.10 10/15/202035,200 shares $40,128.00 -49.9%0.3%0.2 $1.14 9/30/202070,300 shares $87,172.00 +174.6%0.7%0.1 $1.24 9/15/202025,600 shares $28,416.00 -42.3%0.2%0 $1.11 8/31/202044,400 shares $56,832.00 -28.2%0.4%0.1 $1.28 8/14/202061,800 shares $88,992.00 +8.8%0.6%0.1 $1.44Write this ticker symbol down… (Ad)A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made millionaire Tim Bohen is giving you an inside look at the megatrend that’s going to change everything.Discover the #1 company leading this revolution 7/31/202056,800 shares $95,992.00 +11.6%0.5%0.1 $1.69 7/15/202050,900 shares $91,111.00 +110.3%0.5%0.1 $1.79 6/30/202024,200 shares $45,254.00 +505.0%0.2%0.3 $1.87 6/15/20204,000 shares $7,440.00 +263.6%0.0%0.1 $1.86 5/29/20201,100 shares $2,200.00 -8.3%0.0%0 $2.00 5/15/20201,200 shares $2,664.00 -70.7%0.0%0 $2.22 4/30/20204,100 shares $9,348.00 +32.3%0.0%0.9 $2.28 4/15/20203,100 shares $7,254.00 -6.1%0.0%0.5 $2.34 3/31/20203,300 shares $6,468.00 +153.9%0.0%0.5 $1.96 3/13/20201,300 shares $2,782.00 No Change0.0%0.4 $2.14 2/28/20201,300 shares $2,665.00 -74.0%0.0%0.1 $2.05 2/14/20205,000 shares $14,250.00 -24.2%N/A0.4 $2.85 1/31/20206,600 shares $18,876.00 -35.9%0.1%0.5 $2.86 1/15/202010,300 shares $34,402.00 +281.5%0.1%0.8 $3.34 12/31/20192,700 shares $8,505.00 +800.0%0.1%0.2 $3.15 8/15/20195,600 shares $15,680.00 -13.9%0.2%0.4 $2.80 ENTX Short Interest - Frequently Asked Questions What is Entera Bio's current short interest? Short interest is the volume of Entera Bio shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 35,200 shares of ENTX short. Learn More on Entera Bio's current short interest. Is Entera Bio's short interest increasing or decreasing? Entera Bio saw a decrease in short interest in the month of April. As of April 30th, there was short interest totaling 35,200 shares, a decrease of 60.8% from the previous total of 89,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Entera Bio's short interest compare to its competitors? Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Entera Bio: Instil Bio, Inc. (0.19%), Ikena Oncology, Inc. (5.99%), Turnstone Biologics Corp. (5.22%), Curis, Inc. (1.14%), Passage Bio, Inc. (4.28%), Protara Therapeutics, Inc. (5.00%), Elutia Inc. (0.20%), Atara Biotherapeutics, Inc. (9.87%), Cognition Therapeutics, Inc. (0.56%), Genenta Science S.p.A. (0.03%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Entera Bio stock? Short selling ENTX is an investing strategy that aims to generate trading profit from Entera Bio as its price is falling. ENTX shares are trading down $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Entera Bio? A short squeeze for Entera Bio occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ENTX, which in turn drives the price of the stock up even further. How often is Entera Bio's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ENTX, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Instil Bio Short Interest Data Ikena Oncology Short Interest Data Turnstone Biologics Short Interest Data Curis Short Interest Data Passage Bio Short Interest Data Protara Therapeutics Short Interest Data Elutia Short Interest Data Atara Biotherapeutics Short Interest Data Cognition Therapeutics Short Interest Data Genenta Science Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ENTX) was last updated on 5/23/2024 by MarketBeat.com Staff From Our PartnersThis could mean the end of the U.S dollar…Colonial MetalsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe Presidential candidate you should REALLY be worried aboutStansberry ResearchWrite this ticker symbol down…StocksToTrade**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarThis military-backed stock “owns” AI marketPorter & CompanyU.S. Drone Company Receives DoD CertificationThe Tomorrow Investor